Cyclacel Pharmaceuticals, Inc. - COM NEW (CYCC)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
202K
Holdings value Q3 2024
$200K
Value change Q3 2024
-$40.8K
Grand Portfolio weight change Q3 2024
0%
Number of holders
14
Number of buys Q3 2024
4
Number of sells Q3 2024
-5
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 202K $200K -$40.8K $0.99 14
2024 Q2 229K $371K +$263K $1.62 16
2024 Q1 60.6K $127K -$90.8K $2.11 12
2023 Q4 93.9K $250K +$250K $2.67 13